olmesartan has been researched along with Diabetic Angiopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho-Tavares, J; Castro-Faria Neto, H; Estato, V; Freitas, FS; Lessa, MA; Obadia, N; Reis, P; Tibiriçá, E | 1 |
| Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Ogawa, H; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
| Ando, K; Ishibashi, T; Kamioka, M; Maruyama, Y; Nagai, R; Ohkawara, H; Sakamoto, N; Sugimoto, K; Takeishi, Y; Teramoto, T; Uekita, H | 1 |
| Arao, T; Mori, H; Nishida, K; Okada, Y; Tanaka, Y | 1 |
1 trial(s) available for olmesartan and Diabetic Angiopathies
| Article | Year |
|---|---|
Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Resistance; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Telmisartan; Tetrazoles | 2013 |
3 other study(ies) available for olmesartan and Diabetic Angiopathies
| Article | Year |
|---|---|
Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Blood Glucose; Brain; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Enalapril; Heart Ventricles; Hypertension; Imidazoles; Insulin; Leukocyte Rolling; Male; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Streptozocin; Tetrazoles | 2013 |
Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Eating; Endothelium, Vascular; Fatty Liver; Fibrosis; Imidazoles; Insulin Resistance; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Obesity; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Transforming Growth Factor beta1 | 2008 |
Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cells, Cultured; Diabetic Angiopathies; Glycation End Products, Advanced; Imidazoles; Myocytes, Smooth Muscle; NADPH Oxidases; Rabbits; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thiazepines | 2010 |